We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Spatial Biology – News and Features

News

Fluidigm Reports Strong Q1 2013 Results

Revenue up 33% and margins increase 300 basis points compared to Q1 2012.
News

Singapore Single-Cell Research Centre Opens Door for Asian Biological Discoveries

Centre dedicated to diagnosis and treatment derived from single-cell exploration.
News

Bringing a New Perspective to Infectious Disease

Enlisted in the fight against HIV, MIT engineers and scientists contribute new technology, materials and computational studies.
News

Labcyte and FIMM Announce a Collaboration Enabling “Real-Time” Science to Advance Personalized Medicine in Cancer Treatments

Collaboration expected to further the development of personalized medicine in cancer treatment.
News

Ovarian Cancer Stem Cell Study puts Targeted Therapies Within Reach

Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer’s growth and patient prognosis.
News

3D cell Culture Firm Reinnervate and Specialist Oncology CRO Oncotest GmbH Enter Collaboration Agreement

Oncotest to offer enhanced pre-clinical oncology and cancer research screening services incorporating Alvetex®Scaffold 3D cell culture technology.
News

Genome Institute of Singapore and Fluidigm Establish Asia's First Single-Cell Genomics Research Center

Center exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells.
News

Collecting Cancer Data in the ‘Cloud’ Could Lead to More Effective Treatment

Storing music and photos on distant computers via “cloud” technology is nothing new. But Johns Hopkins researchers are now using this tactic to collect detailed information from thousands of cancer cell samples.
News

Horizon Launches SyntheTx Partnership Program

H3 Biomedicine is first partner for program aimed at generating ‘first-in-class’ patient-relevant targets based on synthetic lethality screens.
News

Tracking Stem Cell Reprogramming

Biologists reveal genes key to development of pluripotency, in single cells.
Advertisement